Mumbai: Global pharma major Lupin Limited has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ...

The FDA approved Nufymco as an interchangeable biosimilar to Lucentis, making it the second approved ranibizumab biosimilar ...

Samsung Bioepis Co., Ltd. today announced that the company has begun direct commercialization of BYOOVIZ®, a biosimilar to Lucentis1 (ranibizumab), in Europe. Samsung Bioepis has been working to ...

An overview of the top 10 stories from Optometry Times in 2025.

Learn more about whether Glaukos Corporation or Omnicell, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The use of the preCARDIA system appears safe and feasible for patients with acute decompensated heart failure, with notable reductions in cardiac filling pressures and increased urine output.

Panelists discuss how higher-dose and dual-pathway anti-VEGF agents enable longer intervals, improved fluid control, and more flexible treatment strategies across retinal vascular diseases.

SOUTHLAKE, Texas & YOKNEAM, Israel--(BUSINESS WIRE)--Rapid Medical™, a leading developer of active endovascular devices, announces the completion of patient enrollment in the DISTALS Trial, a ...

By utilizing three wavelength channels, as well as OCT scanning, the Optos Silverstone RGB retinal imaging device allows for ...

The operational cleavage between the US public health and medical care systems contributed to the country’s difficulty in containing community spread of COVID-19 in the pandemic’s first months. We ...

The milestone reflects growing evidence for distal-specific thrombectomy solutions and is reinforced by interim findings that confirmed no safety concerns with TIGERTRIEVER 13. SOUTHLAKE, Texas & ...

For more than 35 years, Carty Eye Associates has been that kind of place, a practice where families send their parents, their ...